Raphael Kelvin
University of Cambridge
36 Papers
54 Citations
Raphael Kelvin is an academic researcher from University of Cambridge. The author has contributed to research in topics: Randomized controlled trial & Psychosocial. The author has an hindex of 14, co-authored 35 publications. Previous affiliations of Raphael Kelvin include Royal College of Paediatrics and Child Health & National Health Service.
Chat about Author
Papers
Clinical and Psychosocial Predictors of Suicide Attempts and Nonsuicidal Self-Injury in the Adolescent Depression Antidepressants and Psychotherapy Trial (ADAPT)
TL;DR: A history of nonsuicidal self-injury prior to treatment is a clinical marker for subsequent suicide attempts and should be as carefully assessed in depressed youths as current suicidal intent and behavior.
617
Selective serotonin reuptake inhibitors (SSRIs) and routine specialist care with and without cognitive behaviour therapy in adolescents with major depression: randomised controlled trial
Ian M. Goodyer,Bernadka Dubicka,Paul Wilkinson,Raphael Kelvin,Chris Roberts,Sarah Byford,Siobhan Breen,Claire Ford,Barbara Barrett,Alison Leech,J. Rothwell,Lydia White,Richard C. Harrington +12 more
TL;DR: For adolescents with moderate to severe major depression there is no evidence that the combination of CBT plus an SSRI in the presence of routine clinical care contributes to an improved outcome by 28 weeks compared with the provision of routineclinical care plus anSSRI alone.
357
Computerised therapies for anxiety and depression in children and young people: A systematic review and meta-analysis
Mary Pennant,Christina E. Loucas,Craig Whittington,Cathy Creswell,Peter Fonagy,Peter Fuggle,Raphael Kelvin,Sabrina Naqvi,Sarah Stockton,Tim Kendall +9 more
TL;DR: Computerised CBT has potential for treating and preventing anxiety and depression in clinical and general populations of young people and further program development and research is required to extend its use and establish its benefit in children.
280
Improving mood with psychoanalytic and cognitive therapies (IMPACT): a pragmatic effectiveness superiority trial to investigate whether specialised psychological treatment reduces the risk for relapse in adolescents with moderate to severe unipolar depression: study protocol for a randomised controlled trial
Ian M. Goodyer,Sonya Tsancheva,Sarah Byford,Bernadka Dubicka,Jonathan Hill,Raphael Kelvin,Shirley Reynolds,Chris Roberts,Robert Senior,John Suckling,Paul Wilkinson,Mary Target,Peter Fonagy +12 more
TL;DR: Whether Cognitive Behavioural Therapy or Short Term Psychoanalytic Therapy is superior in reducing relapse compared with Specialist Clinical Care is determined to determine whether time to recovery and/or relapse are moderated by variations in brain structure and function and selected genetic and hormone biomarkers taken at entry.
A randomised controlled trial of cognitive behaviour therapy in adolescents with major depression treated by selective serotonin reuptake inhibitors. The ADAPT trial.
Ian M. Goodyer,Bernadka Dubicka,Paul Wilkinson,Raphael Kelvin,Chris Roberts,Sarah Byford,Siobhan Breen,Carol Ann Ford,Barbara Barrett,A Leech,J. Rothwell,Lydia White,Richard Harrington +12 more
TL;DR: For moderately to severely depressed adolescents who are non-responsive to a BII, the addition of CBT to fluoxetine plus routine clinical care does not improve outcome or confer protective effects against adverse events and is not cost-effective.